| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.677 | 0.001 | 0.737 | 5 Hydroxytryptamine 4 agonist | 0.737 0.001 CID_3019427 0.374 0.001 CID_101146906 0.342 0.001 CID_101146908 | CID_3019427 | |
| 0.651 | 0.001 | 0.651 | 5 Hydroxytryptamine 4 antagonist | 0.532 0.001 CID_3019427 0.443 0.002 CID_101146906 0.399 0.002 CID_101146908 | ||
| 0.637 | 0.005 | 0.637 | 5 Hydroxytryptamine antagonist | 0.396 0.012 CID_3019427 0.389 0.012 CID_101146906 0.307 0.018 CID_101146908 | ||
| 0.451 | 0.005 | 0.633 | 5 Hydroxytryptamine agonist | 0.633 0.004 CID_3019427 0.342 0.007 CID_101146906 0.364 0.006 CID_101146908 | CID_3019427 | |
| 0.447 | 0.02 | 0.447 | Potassium channel (Voltage-sensitive) blocker | 0.387 0.029 CID_3019427 0.305 0.048 CID_101146906 0.29 0.053 CID_101146908 | ||
| 0.416 | 0.004 | 0.416 | 5 Hydroxytryptamine 1E antagonist | 0.366 0.007 CID_3019427 0.366 0.007 CID_101146906 0.334 0.014 CID_101146908 | ||
| 0.432 | 0.023 | 0.432 | HERG channel blocker | 0.372 0.033 CID_3019427 0.294 0.05 CID_101146906 0.278 0.056 CID_101146908 | ||
| 0.39 | 0.041 | 0.397 | Nootropic | 0.397 0.039 CID_3019427 0.32 0.065 CID_101146906 0.284 0.082 CID_101146908 | CID_3019427 | |
| 0.337 | 0.036 | 0.337 | Potassium channel blocker | 0.244 0.069 CID_3019427 0.21 0.086 CID_101146906 0.199 0.093 CID_101146908 | ||
| 0.314 | 0.032 | 0.314 | Ca(v)3.3 blocker | 0.282 0.059 CID_101146906 0.259 0.087 CID_101146908 | ||
| 0.284 | 0.011 | 0.295 | Dopamine D2 antagonist | 0.295 0.01 CID_101146906 0.188 0.018 CID_101146908 | CID_101146906 | |
| 0.278 | 0.013 | 0.29 | Dopamine antagonist | 0.29 0.012 CID_101146906 0.201 0.019 CID_101146908 | CID_101146906 | |
| 0.277 | 0.016 | 0.277 | 5 Hydroxytryptamine 2B antagonist | 0.131 0.051 CID_3019427 0.181 0.03 CID_101146906 0.141 0.045 CID_101146908 | ||
| 0.266 | 0.019 | 0.266 | 5 Hydroxytryptamine 2 antagonist | 0.157 0.042 CID_101146906 0.13 0.053 CID_101146908 | ||
| 0.224 | 0.005 | 0.528 | 5 Hydroxytryptamine 3 antagonist | 0.528 0.003 CID_3019427 0.07 0.029 CID_101146906 0.063 0.033 CID_101146908 | CID_3019427 | |
| 0.292 | 0.073 | 0.319 | Spasmolytic | 0.271 0.082 CID_3019427 0.319 0.063 CID_101146906 0.208 0.113 CID_101146908 | CID_101146906 | |
| 0.201 | 0.004 | 0.318 | 5 Hydroxytryptamine 3A antagonist | 0.318 0.003 CID_3019427 0.094 0.02 CID_101146906 0.087 0.025 CID_101146908 | CID_3019427 | |
| 0.202 | 0.03 | 0.213 | MAP kinase kinase 5 inhibitor | 0.213 0.021 CID_3019427 0.184 0.055 CID_101146906 0.189 0.047 CID_101146908 | CID_3019427 | |
| 0.306 | 0.137 | 0.319 | Analgesic | 0.319 0.128 CID_3019427 0.286 0.153 CID_101146906 0.301 0.141 CID_101146908 | CID_3019427 | |
| 0.193 | 0.025 | 0.215 | Alpha 2b adrenoreceptor antagonist | 0.215 0.021 CID_3019427 0.183 0.028 CID_101146906 0.111 0.065 CID_101146908 | CID_3019427 | |
| 0.174 | 0.013 | 0.174 | Dopamine D3 antagonist | 0.116 0.021 CID_101146906 0.076 0.035 CID_101146908 | ||
| 0.164 | 0.007 | 0.22 | DNA gyrase inhibitor | 0.22 0.005 CID_3019427 0.147 0.009 CID_101146906 0.145 0.009 CID_101146908 | CID_3019427 | |
| 0.176 | 0.023 | 0.176 | 5 Hydroxytryptamine 2A antagonist | 0.098 0.048 CID_101146906 0.087 0.055 CID_101146908 | ||
| 0.238 | 0.088 | 0.238 | Interleukin agonist | 0.226 0.097 CID_3019427 0.236 0.089 CID_101146906 | ||
| 0.219 | 0.07 | 0.219 | Anticonvulsant | 0.145 0.136 CID_3019427 | ||
| 0.29 | 0.145 | 0.367 | MAP kinase kinase 6 inhibitor | 0.367 0.08 CID_3019427 0.247 0.195 CID_101146906 0.243 0.2 CID_101146908 | CID_3019427 | |
| 0.146 | 0.013 | 0.146 | Glutamate (mGluR7) agonist | 0.131 0.021 CID_3019427 0.123 0.028 CID_101146906 0.118 0.032 CID_101146908 | ||
| 0.298 | 0.167 | 0.315 | 5 Hydroxytryptamine release inhibitor | 0.315 0.149 CID_3019427 | CID_3019427 | |
| 0.17 | 0.041 | 0.17 | Anesthetic local | 0.129 0.061 CID_101146906 0.114 0.071 CID_101146908 | ||
| 0.224 | 0.1 | 0.224 | Cardiotonic | 0.171 0.15 CID_3019427 0.207 0.112 CID_101146906 0.177 0.143 CID_101146908 | ||
| 0.156 | 0.036 | 0.177 | Alpha adrenoreceptor antagonist | 0.177 0.031 CID_101146906 0.095 0.06 CID_101146908 | CID_101146906 | |
| 0.203 | 0.086 | 0.203 | ErbB-1 antagonist | 0.201 0.088 CID_101146906 0.176 0.122 CID_101146908 | ||
| 0.146 | 0.034 | 0.146 | Alpha 2c adrenoreceptor antagonist | 0.119 0.05 CID_3019427 0.133 0.041 CID_101146906 | ||
| 0.123 | 0.011 | 0.193 | Protein kinase C eta inhibitor | 0.193 0.005 CID_3019427 0.119 0.013 CID_101146906 0.114 0.014 CID_101146908 | CID_3019427 | |
| 0.114 | 0.004 | 0.223 | 5 Hydroxytryptamine 3B antagonist | 0.223 0.003 CID_3019427 0.047 0.016 CID_101146906 0.041 0.02 CID_101146908 | CID_3019427 | |
| 0.116 | 0.01 | 0.172 | Protein kinase C epsilon inhibitor | 0.172 0.004 CID_3019427 0.098 0.013 CID_101146906 0.091 0.015 CID_101146908 | CID_3019427 | |
| 0.207 | 0.103 | 0.255 | MAP kinase kinase 3 inhibitor | 0.255 0.027 CID_3019427 0.191 0.151 CID_101146906 0.194 0.139 CID_101146908 | CID_3019427 | |
| 0.188 | 0.086 | 0.198 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.198 0.075 CID_3019427 0.187 0.086 CID_101146906 0.156 0.124 CID_101146908 | CID_3019427 | |
| 0.114 | 0.021 | 0.184 | Dopamine D1 antagonist | 0.184 0.012 CID_101146906 0.141 0.016 CID_101146908 | CID_101146906 | |
| 0.152 | 0.075 | 0.152 | Cholinergic | 0.142 0.083 CID_3019427 0.133 0.092 CID_101146906 0.118 0.111 CID_101146908 | ||
| 0.089 | 0.017 | 0.089 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.138 | 0.069 | 0.138 | Calcium channel blocker | |||
| 0.109 | 0.04 | 0.113 | Alpha 1 adrenoreceptor antagonist | 0.113 0.039 CID_101146906 | CID_101146906 | |
| 0.103 | 0.036 | 0.107 | ATPase (Vacuolar H+) inhibitor | 0.107 0.031 CID_3019427 0.107 0.031 CID_101146906 0.105 0.034 CID_101146908 | CID_101146906 | |
| 0.1 | 0.036 | 0.16 | Alpha 2a adrenoreceptor antagonist | 0.16 0.02 CID_3019427 0.127 0.027 CID_101146906 | CID_3019427 | |
| 0.105 | 0.048 | 0.183 | Protein kinase C delta inhibitor | 0.183 0.011 CID_3019427 0.097 0.055 CID_101146906 0.093 0.059 CID_101146908 | CID_3019427 | |
| 0.111 | 0.054 | 0.111 | Chemokine receptor antagonist | 0.098 0.064 CID_3019427 0.085 0.08 CID_101146906 | ||
| 0.125 | 0.069 | 0.125 | Nav1.3 sodium channel blocker | |||
| 0.078 | 0.024 | 0.078 | Alpha 1 adrenoreceptor agonist | 0.077 0.024 CID_101146906 0.056 0.041 CID_101146908 | ||
| 0.091 | 0.04 | 0.091 | Alpha 1a adrenoreceptor antagonist | 0.086 0.042 CID_101146906 | ||
| 0.095 | 0.048 | 0.095 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.085 | 0.039 | 0.085 | 5 Hydroxytryptamine 1F antagonist | 0.069 0.051 CID_3019427 0.06 0.059 CID_101146906 | ||
| 0.094 | 0.049 | 0.205 | Protein kinase A inhibitor | 0.205 0.013 CID_3019427 0.087 0.055 CID_101146906 0.073 0.068 CID_101146908 | CID_3019427 | |
| 0.094 | 0.052 | 0.12 | Alpha 2 adrenoreceptor antagonist | 0.12 0.037 CID_3019427 0.102 0.047 CID_101146906 0.076 0.072 CID_101146908 | CID_3019427 | |
| 0.049 | 0.007 | 0.049 | CC chemokine 1 receptor antagonist | 0.042 0.008 CID_101146906 0.047 0.007 CID_101146908 | ||
| 0.137 | 0.096 | 0.137 | Sigma receptor agonist | 0.12 0.115 CID_101146906 0.121 0.114 CID_101146908 | ||
| 0.086 | 0.046 | 0.086 | CC chemokine receptor antagonist | |||
| 0.074 | 0.035 | 0.074 | Dopamine D4 antagonist | 0.051 0.048 CID_101146906 | ||
| 0.106 | 0.069 | 0.111 | EphA2 antagonist | 0.111 0.063 CID_3019427 0.097 0.079 CID_101146906 | CID_3019427 | |
| 0.057 | 0.021 | 0.057 | CC chemokine 3 receptor antagonist | |||
| 0.079 | 0.044 | 0.083 | Nav1.8 sodium channel blocker | 0.081 0.041 CID_3019427 0.083 0.039 CID_101146906 0.083 0.039 CID_101146908 | CID_101146908 | |
| 0.098 | 0.063 | 0.098 | Insulin receptor antagonist | |||
| 0.139 | 0.107 | 0.146 | Interleukin 6 antagonist | 0.143 0.099 CID_3019427 0.146 0.095 CID_101146906 | CID_101146906 | |
| 0.085 | 0.054 | 0.085 | ErbB-3 antagonist | |||
| 0.148 | 0.12 | 0.152 | P-glycoprotein inhibitor | 0.152 0.114 CID_101146906 | CID_101146906 | |
| 0.04 | 0.011 | 0.055 | Protein kinase C beta II inhibitor | 0.055 0.005 CID_3019427 0.04 0.011 CID_101146906 0.039 0.012 CID_101146908 | CID_3019427 | |
| 0.038 | 0.011 | 0.046 | Protein kinase C beta I inhibitor | 0.046 0.005 CID_3019427 0.037 0.013 CID_101146906 0.037 0.013 CID_101146908 | CID_3019427 | |
| 0.07 | 0.044 | 0.152 | Protein kinase C alpha inhibitor | 0.152 0.01 CID_3019427 0.064 0.053 CID_101146906 | CID_3019427 | |
| 0.113 | 0.088 | 0.114 | DNA repair enzyme inhibitor | 0.114 0.085 CID_3019427 | CID_3019427 | |
| 0.059 | 0.034 | 0.149 | Acetylcholine muscarinic agonist | 0.149 0.01 CID_3019427 | CID_3019427 | |
| 0.052 | 0.03 | 0.052 | Sodium/calcium exchanger inhibitor | |||
| 0.139 | 0.121 | 0.162 | ATPase inhibitor | 0.162 0.083 CID_101146906 | CID_101146906 | |
| 0.071 | 0.053 | 0.071 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.069 | 0.053 | 0.069 | Alpha 1b adrenoreceptor antagonist | 0.065 0.057 CID_101146906 | ||
| 0.036 | 0.023 | 0.036 | Ceramide glucosyltransferase inhibitor | |||
| 0.085 | 0.077 | 0.085 | Butyrylcholinesterase inhibitor | |||
| 0.046 | 0.039 | 0.046 | CC chemokine receptor 2B antagonist | |||
| 0.029 | 0.023 | 0.037 | DNA topoisomerase IV inhibitor | 0.037 0.01 CID_3019427 | CID_3019427 | |
| 0.104 | 0.098 | 0.104 | Acetylcholinesterase inhibitor | |||
| 0.078 | 0.073 | 0.088 | Antiadrenergic | 0.088 0.064 CID_101146906 | CID_101146906 | |
| 0.057 | 0.052 | 0.057 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.083 | 0.08 | 0.083 | Glutamate release inhibitor | |||
| 0.051 | 0.048 | 0.051 | Alpha 1d adrenoreceptor antagonist | |||
| 0.033 | 0.03 | 0.041 | Antibiotic Aminoglycoside-like | 0.041 0.02 CID_3019427 0.033 0.031 CID_101146906 0.034 0.029 CID_101146908 | CID_3019427 | |
| 0.059 | 0.056 | 0.087 | Alpha adrenoreceptor agonist | 0.087 0.034 CID_3019427 0.069 0.047 CID_101146906 | CID_3019427 | |
| 0.058 | 0.055 | 0.058 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.129 | 0.127 | 0.134 | Amyloid beta precursor protein antagonist | 0.134 0.12 CID_101146906 | CID_101146906 | |
| 0.075 | 0.073 | 0.19 | Acetylcholine agonist | 0.19 0.016 CID_3019427 | CID_3019427 | |
| 0.074 | 0.074 | 0.085 | Adrenaline antagonist | 0.085 0.064 CID_101146906 | CID_101146906 | |
| 0.067 | 0.067 | 0.099 | Focal adhesion kinase 1 inhibitor | 0.099 0.031 CID_3019427 | CID_3019427 | |
| 0.089 | 0.09 | 0.094 | Toll-Like receptor 4 antagonist | 0.094 0.08 CID_101146906 | CID_101146906 | |
| 0.059 | 0.063 | 0.084 | Potassium channel large-conductance Ca-activated activator | 0.084 0.033 CID_3019427 0.062 0.057 CID_101146908 | CID_3019427 | |
| 0.069 | 0.074 | 0.11 | Adrenaline agonist | 0.071 0.07 CID_3019427 0.097 0.039 CID_101146906 0.11 0.031 CID_101146908 | CID_101146908 | |
| 0.086 | 0.093 | 0.135 | AMP-activated protein kinase stimulant | 0.123 0.046 CID_101146906 0.135 0.038 CID_101146908 | CID_101146908 | |
| 0.112 | 0.125 | 0.141 | Farnesoid X receptor antagonist | 0.124 0.094 CID_101146906 0.141 0.063 CID_101146908 | CID_101146908 | |
| 0.086 | 0.1 | 0.123 | Topoisomerase II inhibitor | 0.123 0.065 CID_3019427 0.113 0.073 CID_101146906 | CID_3019427 | |
| 0.043 | 0.065 | 0.068 | 5 Hydroxytryptamine 7 antagonist | 0.068 0.038 CID_3019427 | CID_3019427 | |
| 0.158 | 0.187 | 0.197 | Nitric-oxide synthase stimulant | 0.197 0.094 CID_3019427 | CID_3019427 | |
| 0.134 | 0.168 | 0.24 | Antiamyloidogenic | 0.24 0.076 CID_101146906 | CID_101146906 | |
| 0.117 | 0.152 | 0.182 | Tumour necrosis factor antagonist | 0.182 0.066 CID_3019427 | CID_3019427 | |
| 0.093 | 0.133 | 0.125 | Interleukin 4 antagonist | 0.125 0.079 CID_101146906 | CID_101146906 | |
| 0.052 | 0.094 | 0.064 | Beta 2 adrenoreceptor agonist | 0.059 0.053 CID_101146906 0.064 0.035 CID_101146908 | CID_101146908 | |
| 0.03 | 0.071 | 0.045 | Dopamine transporter inhibitor | 0.045 0.037 CID_3019427 | CID_3019427 | |
| 0.093 | 0.136 | 0.121 | Protein kinase C nu inhibitor | 0.121 0.091 CID_3019427 | CID_3019427 | |
| 0.084 | 0.132 | 0.115 | Acetylcholine release stimulant | 0.115 0.057 CID_3019427 | CID_3019427 | |
| 0.109 | 0.161 | 0.13 | Death-associated protein kinase 1 inhibitor | 0.13 0.08 CID_3019427 | CID_3019427 | |
| 0.075 | 0.13 | 0.166 | Protein kinase C gamma inhibitor | 0.166 0.023 CID_3019427 | CID_3019427 | |
| 0.125 | 0.182 | 0.196 | Catenin beta inhibitor | 0.196 0.035 CID_3019427 | CID_3019427 | |
| 0.019 | 0.081 | 0.094 | Factor Xa inhibitor | 0.094 0.015 CID_3019427 | CID_3019427 | |
| 0.069 | 0.131 | 0.08 | T cell inhibitor | 0.08 0.065 CID_3019427 | CID_3019427 | |
| 0.037 | 0.102 | 0.067 | Adrenaline uptake inhibitor | 0.067 0.037 CID_3019427 | CID_3019427 | |
| 0.036 | 0.1 | 0.123 | Alpha 2 adrenoreceptor agonist | 0.123 0.01 CID_3019427 | CID_3019427 | |
| 0.066 | 0.136 | 0.109 | 5 Hydroxytryptamine 3A agonist | 0.109 0.066 CID_3019427 | CID_3019427 | |
| 0.12 | 0.194 | 0.169 | Death-associated protein kinase 2 inhibitor | 0.169 0.07 CID_3019427 | CID_3019427 | |
| 0.03 | 0.105 | 0.049 | Alpha 1L adrenoreceptor agonist | 0.049 0.018 CID_3019427 | CID_3019427 | |
| 0.081 | 0.157 | 0.1 | Interleukin 8 antagonist | 0.1 0.096 CID_3019427 | CID_3019427 | |
| 0.077 | 0.155 | 0.107 | CDK3/cyclin E inhibitor | 0.107 0.074 CID_3019427 | CID_3019427 | |
| 0.173 | 0.258 | 0.228 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.228 0.1 CID_3019427 | CID_3019427 | |
| 0.061 | 0.147 | 0.087 | Polo-like kinase-1 inhibitor | 0.087 0.067 CID_3019427 | CID_3019427 | |
| 0.074 | 0.161 | 0.103 | Cyclooxygenase 3 inhibitor | 0.103 0.098 CID_3019427 | CID_3019427 | |
| 0.164 | 0.254 | 0.215 | Toll-Like receptor 7 agonist | 0.215 0.183 CID_101146908 | CID_101146908 | |
| 0.061 | 0.157 | 0.163 | Protein kinase C zeta inhibitor | 0.163 0.017 CID_3019427 0.092 0.061 CID_101146908 | CID_3019427 | |
| 0.16 | 0.26 | 0.211 | Toll-Like receptor agonist | 0.211 0.189 CID_101146908 | CID_101146908 | |
| 0.05 | 0.16 | 0.146 | Protein kinase C mu inhibitor | 0.146 0.028 CID_3019427 | CID_3019427 | |
| 0.079 | 0.194 | 0.149 | Amyloid beta aggregation inhibitor | 0.149 0.108 CID_101146906 | CID_101146906 | |
| 0.029 | 0.157 | 0.107 | Check point kinase 1 inhibitor | 0.107 0.026 CID_3019427 | CID_3019427 | |
| 0.027 | 0.179 | 0.11 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.11 0.031 CID_3019427 | CID_3019427 | |
| 0.026 | 0.192 | 0.064 | Protein kinase C iota inhibitor | 0.064 0.037 CID_3019427 | CID_3019427 | |
| 0.057 | 0.238 | 0.124 | Estrogen antagonist | 0.124 0.048 CID_101146908 | CID_101146908 | |
| 0.036 | 0.217 | 0.099 | Pim-3 kinase inhibitor | 0.099 0.047 CID_3019427 | CID_3019427 | |
| 0.023 | 0.205 | 0.076 | Protein kinase C beta inhibitor | 0.076 0.036 CID_3019427 | CID_3019427 | |
| 0.027 | 0.241 | 0.093 | Check point kinase 2 inhibitor | 0.093 0.072 CID_3019427 | CID_3019427 | |
| 0.022 | 0.24 | 0.073 | Leucine-rich repeat kinase 2 inhibitor | 0.073 0.065 CID_3019427 | CID_3019427 | |
| 0.017 | 0.247 | 0.066 | Neuronal nicotinic receptor antagonist | 0.066 0.049 CID_3019427 | CID_3019427 | |
| 0.056 | 0.3 | 0.141 | Heat shock protein 90 antagonist | 0.141 0.084 CID_3019427 | CID_3019427 | |
| 0.035 | 0.317 | 0.107 | Estrogen receptor beta antagonist | 0.107 0.051 CID_101146908 | CID_101146908 | |
| 0.032 | 0.338 | 0.123 | Cyclin-dependent kinase 7 inhibitor | 0.123 0.082 CID_3019427 | CID_3019427 | |
| 0.069 | 0.481 | 0.262 | Antibacterial | 0.262 0.165 CID_3019427 | CID_3019427 | |
| 0.104 | 0.516 | 0.235 | 5 Hydroxytryptamine uptake stimulant | 0.235 0.097 CID_3019427 | CID_3019427 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |